Jiyeong Lee

Uijeongbu-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Identifying predictive proteomic biomarkers of selective serotonin reuptake inhibitor treatment effect in depression.

Identifying predictive proteomic biomarkers of selective serotonin reuptake inhibitor treatment effect in depression.

Journal: Biomarkers in medicine

Published: March 11, 2026

Human serum hypoxanthine as a biomarker to predict recurrent major depressive disorder: a cross-sectional metabolomic study.

Human serum hypoxanthine as a biomarker to predict recurrent major depressive disorder: a cross-sectional metabolomic study.

Journal: Metabolic brain disease

Published: November 18, 2025

Metabolic alterations in the serum of patients with acute ischemic stroke.

Metabolic alterations in the serum of patients with acute ischemic stroke.

Journal: Bioanalysis

Published: October 15, 2025

Correction: Serum L-selectin levels as predictive markers for chronic major depressive disorder progression.

Correction: Serum L-selectin levels as predictive markers for chronic major depressive disorder progression.

Journal: Annals of general psychiatry

Published: August 22, 2025

Alterations in serum nudifloramide associated with response to diverse pharmacological treatments in major depressive disorder: a preliminary study.

Alterations in serum nudifloramide associated with response to diverse pharmacological treatments in major depressive disorder: a preliminary study.

Journal: Metabolic brain disease

Published: August 12, 2025

Biomarker for Diagnosis and Monitoring of Treatment Response in Major Depressive Disorder: Changes in Serum L-Glutamine Levels.

Biomarker for Diagnosis and Monitoring of Treatment Response in Major Depressive Disorder: Changes in Serum L-Glutamine Levels.

Journal: Biomedical chromatography : BMC

Published: May 27, 2025

Molecular Characteristics of Spontaneous Remission in Major Depressive Disorder: Changes in Serum Acetylcarnitine and Glycerophosphcholine Levels.

Molecular Characteristics of Spontaneous Remission in Major Depressive Disorder: Changes in Serum Acetylcarnitine and Glycerophosphcholine Levels.

Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Published: April 16, 2025

Machine learning-based prediction model for long-term mortality after ischemic stroke.

Machine learning-based prediction model for long-term mortality after ischemic stroke.

Journal: Scientific reports

Published: November 09, 2024

Common protein networks for various drug regimens of major depression are associated with complement and immunity.

Common protein networks for various drug regimens of major depression are associated with complement and immunity.

Journal: Journal of psychopharmacology (Oxford, England)

Published: August 16, 2024

Serum proteomic changes related to residual impairment in remittent depression are associated with immune and inflammatory processes.

Serum proteomic changes related to residual impairment in remittent depression are associated with immune and inflammatory processes.

Journal: Scientific reports

Published: June 14, 2024

Serum protein profiling reveals mechanism of activated thrombus formation in patients with stroke and atrial fibrillation.

Serum protein profiling reveals mechanism of activated thrombus formation in patients with stroke and atrial fibrillation.

Journal: Scientific reports

Published: February 28, 2024

Serum L-selectin levels as predictive markers for chronic major depressive disorder progression.

Serum L-selectin levels as predictive markers for chronic major depressive disorder progression.

Journal: Annals of general psychiatry

Published: November 29, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026